Xi'an Xice Testing Technology Co., Ltd. (SHE:301306)
China · Delayed Price · Currency is CNY 100.42
-0.78 (-0.77%)
At close: Feb 13, 2026
SHE:301306 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 299.49 | 386.71 | 288.15 | 302.91 | 243.5 | 200.2 |
Other Revenue | 2.1 | 2.1 | 2.94 | 1.24 | 2.03 | 1.99 |
| 301.59 | 388.81 | 291.09 | 304.15 | 245.53 | 202.19 | |
Revenue Growth (YoY) | -27.84% | 33.57% | -4.29% | 23.87% | 21.43% | 22.79% |
Cost of Revenue | 288.11 | 359.87 | 203.21 | 144.46 | 100.06 | 83.16 |
Gross Profit | 13.48 | 28.94 | 87.89 | 159.69 | 145.47 | 119.03 |
Selling, General & Admin | 111.95 | 115.08 | 113.82 | 72.91 | 56.57 | 48.87 |
Research & Development | 17.03 | 17.65 | 19.28 | 16.86 | 10.61 | 8.21 |
Other Operating Expenses | 2.47 | 0.64 | -0.11 | -1.54 | 1.12 | -5.8 |
Operating Expenses | 143.3 | 150.68 | 153.97 | 100.15 | 71.74 | 51.63 |
Operating Income | -129.81 | -121.75 | -66.08 | 59.54 | 73.74 | 67.4 |
Interest Expense | -12.38 | -11.41 | -5.9 | -3.61 | -2.23 | -4.04 |
Interest & Investment Income | 4.01 | 5.37 | 16.52 | 8.78 | 2.34 | 0.25 |
Currency Exchange Gain (Loss) | -0.37 | -0.37 | -0.13 | 0 | 0.13 | -0.05 |
Other Non Operating Income (Expenses) | -0.16 | -0.35 | -0.51 | -0.04 | -0.31 | -1.97 |
EBT Excluding Unusual Items | -138.71 | -128.5 | -56.1 | 64.67 | 73.67 | 61.59 |
Impairment of Goodwill | - | - | - | -2.9 | - | - |
Gain (Loss) on Sale of Investments | -0.51 | 0.02 | 1.24 | 0.32 | -0.19 | 0.19 |
Gain (Loss) on Sale of Assets | 0.09 | 0.14 | 0.45 | 0.02 | -0.45 | - |
Asset Writedown | -20.85 | -20.42 | -0.23 | - | - | - |
Other Unusual Items | -0.91 | -2.28 | 5.48 | 19.48 | 6.3 | -1.89 |
Pretax Income | -160.9 | -151.05 | -49.16 | 81.59 | 79.33 | 59.89 |
Income Tax Expense | 5.61 | 3.43 | -0.47 | 15.8 | 11.76 | 9.96 |
Earnings From Continuing Operations | -166.51 | -154.48 | -48.69 | 65.78 | 67.58 | 49.93 |
Minority Interest in Earnings | -2.96 | -3.79 | -3.01 | -1.12 | -0.53 | -0.21 |
Net Income | -169.47 | -158.27 | -51.7 | 64.67 | 67.05 | 49.72 |
Net Income to Common | -169.47 | -158.27 | -51.7 | 64.67 | 67.05 | 49.72 |
Net Income Growth | - | - | - | -3.55% | 34.84% | 49.06% |
Shares Outstanding (Basic) | 84 | 84 | 85 | 72 | 63 | 61 |
Shares Outstanding (Diluted) | 84 | 84 | 85 | 72 | 63 | 61 |
Shares Change (YoY) | -1.49% | -0.67% | 17.95% | 13.60% | 3.99% | 1.48% |
EPS (Basic) | -2.02 | -1.88 | -0.61 | 0.90 | 1.06 | 0.82 |
EPS (Diluted) | -2.02 | -1.88 | -0.61 | 0.90 | 1.06 | 0.82 |
EPS Growth | - | - | - | -15.09% | 29.67% | 46.89% |
Free Cash Flow | -173.78 | -309.13 | -363.37 | -49.34 | -14.81 | -16.52 |
Free Cash Flow Per Share | -2.07 | -3.67 | -4.29 | -0.69 | -0.23 | -0.27 |
Dividend Per Share | - | - | - | 0.150 | - | - |
Gross Margin | 4.47% | 7.44% | 30.19% | 52.50% | 59.25% | 58.87% |
Operating Margin | -43.04% | -31.31% | -22.70% | 19.57% | 30.03% | 33.33% |
Profit Margin | -56.19% | -40.71% | -17.76% | 21.26% | 27.31% | 24.59% |
Free Cash Flow Margin | -57.62% | -79.51% | -124.83% | -16.22% | -6.03% | -8.17% |
EBITDA | -71.81 | -77.56 | -40.33 | 78.24 | 89.25 | 79.49 |
EBITDA Margin | -23.81% | -19.95% | -13.85% | 25.72% | 36.35% | 39.31% |
D&A For EBITDA | 58.01 | 44.19 | 25.76 | 18.71 | 15.51 | 12.09 |
EBIT | -129.81 | -121.75 | -66.08 | 59.54 | 73.74 | 67.4 |
EBIT Margin | -43.04% | -31.31% | -22.70% | 19.57% | 30.03% | 33.33% |
Effective Tax Rate | - | - | - | 19.37% | 14.82% | 16.63% |
Revenue as Reported | 301.59 | 388.81 | 291.09 | 304.15 | 245.53 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.